Schou M, Amdisen A, Eskjaer Jensen S, Olsen T
Br Med J. 1968 Sep 21;3(5620):710-3. doi: 10.1136/bmj.3.5620.710.
Of 330 patients given lithium for recurrent manic-depressive disorder 12 developed goitre after treatment periods of five months to two years. All the patients remained clinically euthyroid. Pressure symptoms necessitated subtotal thyroidectomy in two patients. In 9 out of 10 patients with goitre, and in two out of seven without goitre study with radioactive iodine showed abnormal findings in iodine metabolism. Discontinuance of lithium led to disappearance of goitres, while thyroid metabolism returned to normal. Thyroxine or desiccated thyroid produced shrinkage of the gland in spite of continued lithium medication.
在330例接受锂盐治疗复发性躁狂抑郁症的患者中,有12例在治疗5个月至2年期间出现甲状腺肿。所有患者临床上甲状腺功能仍正常。两名患者因压迫症状而行甲状腺次全切除术。在10例有甲状腺肿的患者中,9例以及7例无甲状腺肿的患者中的2例,放射性碘研究显示碘代谢有异常发现。停用锂盐后甲状腺肿消失,而甲状腺代谢恢复正常。尽管继续服用锂盐,甲状腺素或甲状腺干粉仍使腺体缩小。